Aveanna Healthcare Holdings (AVAH) is upgraded to Buy, reflecting improved profitability and resilient demand for home healthcare services. AVAH's Q4 2025 net income surged, but adjusted EPS was $0.17 due to one-time tax benefits and merger costs. FY 2026 revenue guidance of $2.54–$2.56 billion disappointed, while adjusted EBITDA guidance slightly exceeded consensus.
Aveanna Healthcare (NASDAQ: AVAH) reported fourth-quarter and full-year 2025 results that management said reflected continued progress in its preferred payer strategy, improving labor trends, and rate initiatives across its home- and community-based care platform. Executives also provided initial commentary on a newly announced acquisition and issued 2026 guidance that excludes any contribution from the pending deal.
Aveanna Healthcare Holdings Inc. (AVAH) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.05 per share a year ago.
ATLANTA, March 19, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period and fiscal year ended January 3, 2026.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
ATLANTA, March 12, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Family First Holding, LLC ("Family First Homecare").
Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Investors may review the information on the company's upcoming Q4 2025 earning report for the latest details on
ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
Counterpoint Mutual Funds LLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 321,757 shares of the company's stock, valued at approximately $2,854,000. Aveanna Healthcare accounts for
ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care in the home, announced today that Aveanna Home Health and Hospice, a division of Aveanna Healthcare, has been awarded a Disease Program Certification for Heart Failure under the CHAP Disease Program Standards. CHAP certification demonstrates that Aveanna Home Health and Hospice meets the industry's highest nationally recognized standards.
Aveanna (AVAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BAYRY, DAKT, ZTO, LRLCY and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on January 21, 2026.
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) has received a consensus rating of "Hold" from the eleven research firms that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target
Aveanna Healthcare Holdings Inc. (AVAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027).
Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) and Elanco Animal Health (NYSE: ELAN - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Ratings This is a breakdown of
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
This home-based care provider reported notable insider selling as its shares marked strong gains over the past year.